1 Study Coverage
    1.1 Nuclear Medicine Diagnostic (SPECT and PET) Product Introduction
    1.2 Market by Type
        1.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 SPECT
        1.2.3 PET
    1.3 Market by Application
        1.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Neurology
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Estimates and Forecasts 2017-2028
    2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region
        2.4.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2017-2022)
        2.4.2 Global Sales Nuclear Medicine Diagnostic (SPECT and PET) by Region (2023-2028)
    2.5 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region
        2.5.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region (2017-2022)
        2.5.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Manufacturers
        3.1.1 Global Top Nuclear Medicine Diagnostic (SPECT and PET) Manufacturers by Sales (2017-2022)
        3.1.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclear Medicine Diagnostic (SPECT and PET) in 2021
    3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Manufacturers
        3.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Nuclear Medicine Diagnostic (SPECT and PET) Revenue in 2021
    3.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type
        4.1.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Historical Sales by Type (2017-2022)
        4.1.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Type (2017-2028)
    4.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type
        4.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Historical Revenue by Type (2017-2022)
        4.2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Type (2017-2028)
    4.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Type
        4.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Type (2017-2022)
        4.3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application
        5.1.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Historical Sales by Application (2017-2022)
        5.1.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2017-2028)
    5.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application
        5.2.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Historical Revenue by Application (2017-2022)
        5.2.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2017-2028)
    5.3 Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Application
        5.3.1 Global Nuclear Medicine Diagnostic (SPECT and PET) Price by Application (2017-2022)
        5.3.2 Global Nuclear Medicine Diagnostic (SPECT and PET) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Type
        6.1.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2028)
        6.1.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2028)
    6.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Application
        6.2.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2028)
        6.2.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2028)
    6.3 North America Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Country
        6.3.1 North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2028)
        6.3.2 North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Type
        7.1.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2028)
        7.1.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2028)
    7.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Application
        7.2.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2028)
        7.2.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2028)
    7.3 Europe Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Country
        7.3.1 Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2028)
        7.3.2 Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Type
        8.1.1 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2028)
    8.2 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Application
        8.2.1 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2028)
    8.3 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Region
        8.3.1 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Type
        9.1.1 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2028)
        9.1.2 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2028)
    9.2 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Application
        9.2.1 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2028)
        9.2.2 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2028)
    9.3 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Country
        9.3.1 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2028)
        9.3.2 Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Type
        10.1.1 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Application
        10.2.1 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Market Size by Country
        10.3.1 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GE Healthcare
        11.1.1 GE Healthcare Corporation Information
        11.1.2 GE Healthcare Overview
        11.1.3 GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GE Healthcare Recent Developments
    11.2 Siemens Healthineers
        11.2.1 Siemens Healthineers Corporation Information
        11.2.2 Siemens Healthineers Overview
        11.2.3 Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Siemens Healthineers Recent Developments
    11.3 Philips Healthcare
        11.3.1 Philips Healthcare Corporation Information
        11.3.2 Philips Healthcare Overview
        11.3.3 Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Philips Healthcare Recent Developments
    11.4 Mediso
        11.4.1 Mediso Corporation Information
        11.4.2 Mediso Overview
        11.4.3 Mediso Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Mediso Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Mediso Recent Developments
    11.5 Spectrum Dynamics
        11.5.1 Spectrum Dynamics Corporation Information
        11.5.2 Spectrum Dynamics Overview
        11.5.3 Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Spectrum Dynamics Recent Developments
    11.6 Bruker
        11.6.1 Bruker Corporation Information
        11.6.2 Bruker Overview
        11.6.3 Bruker Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Bruker Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Bruker Recent Developments
    11.7 SurgicEye
        11.7.1 SurgicEye Corporation Information
        11.7.2 SurgicEye Overview
        11.7.3 SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 SurgicEye Recent Developments
    11.8 MIE
        11.8.1 MIE Corporation Information
        11.8.2 MIE Overview
        11.8.3 MIE Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 MIE Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 MIE Recent Developments
    11.9 MILabs
        11.9.1 MILabs Corporation Information
        11.9.2 MILabs Overview
        11.9.3 MILabs Nuclear Medicine Diagnostic (SPECT and PET) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 MILabs Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 MILabs Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Nuclear Medicine Diagnostic (SPECT and PET) Industry Chain Analysis
    12.2 Nuclear Medicine Diagnostic (SPECT and PET) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Nuclear Medicine Diagnostic (SPECT and PET) Production Mode & Process
    12.4 Nuclear Medicine Diagnostic (SPECT and PET) Sales and Marketing
        12.4.1 Nuclear Medicine Diagnostic (SPECT and PET) Sales Channels
        12.4.2 Nuclear Medicine Diagnostic (SPECT and PET) Distributors
    12.5 Nuclear Medicine Diagnostic (SPECT and PET) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Nuclear Medicine Diagnostic (SPECT and PET) Industry Trends
    13.2 Nuclear Medicine Diagnostic (SPECT and PET) Market Drivers
    13.3 Nuclear Medicine Diagnostic (SPECT and PET) Market Challenges
    13.4 Nuclear Medicine Diagnostic (SPECT and PET) Market Restraints
14 Key Findings in The Global Nuclear Medicine Diagnostic (SPECT and PET) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of SPECT
    Table 3. Major Manufacturers of PET
    Table 4. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2017-2022) & (K Units)
    Table 7. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Region (2017-2022)
    Table 8. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2023-2028) & (K Units)
    Table 9. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Region (2023-2028)
    Table 10. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Region (2017-2022)
    Table 12. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Region (2023-2028)
    Table 14. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Manufacturers (2017-2022)
    Table 16. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Manufacturers (2017-2022)
    Table 18. Nuclear Medicine Diagnostic (SPECT and PET) Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Nuclear Medicine Diagnostic (SPECT and PET) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Nuclear Medicine Diagnostic (SPECT and PET) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Diagnostic (SPECT and PET) as of 2021)
    Table 21. Nuclear Medicine Diagnostic (SPECT and PET) Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Nuclear Medicine Diagnostic (SPECT and PET) Product Offered
    Table 23. Date of Manufacturers Enter into Nuclear Medicine Diagnostic (SPECT and PET) Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2022) & (K Units)
    Table 26. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2023-2028) & (K Units)
    Table 27. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Type (2017-2022)
    Table 28. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Type (2023-2028)
    Table 29. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Type (2017-2022)
    Table 32. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Type (2023-2028)
    Table 33. Nuclear Medicine Diagnostic (SPECT and PET) Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Nuclear Medicine Diagnostic (SPECT and PET) Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2022) & (K Units)
    Table 36. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2023-2028) & (K Units)
    Table 37. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Application (2017-2022)
    Table 38. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Application (2023-2028)
    Table 39. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Application (2017-2022)
    Table 42. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Application (2023-2028)
    Table 43. Nuclear Medicine Diagnostic (SPECT and PET) Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Nuclear Medicine Diagnostic (SPECT and PET) Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2022) & (K Units)
    Table 46. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2023-2028) & (K Units)
    Table 47. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2022) & (K Units)
    Table 50. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2023-2028) & (K Units)
    Table 51. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2022) & (K Units)
    Table 54. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2023-2028) & (K Units)
    Table 55. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue by Country (2023-2028) & (US$ Million)
    Table 105. GE Healthcare Corporation Information
    Table 106. GE Healthcare Description and Major Businesses
    Table 107. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. GE Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. GE Healthcare Recent Developments
    Table 110. Siemens Healthineers Corporation Information
    Table 111. Siemens Healthineers Description and Major Businesses
    Table 112. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Siemens Healthineers Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Siemens Healthineers Recent Developments
    Table 115. Philips Healthcare Corporation Information
    Table 116. Philips Healthcare Description and Major Businesses
    Table 117. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Philips Healthcare Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Philips Healthcare Recent Developments
    Table 120. Mediso Corporation Information
    Table 121. Mediso Description and Major Businesses
    Table 122. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Mediso Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Mediso Recent Developments
    Table 125. Spectrum Dynamics Corporation Information
    Table 126. Spectrum Dynamics Description and Major Businesses
    Table 127. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. Spectrum Dynamics Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Spectrum Dynamics Recent Developments
    Table 130. Bruker Corporation Information
    Table 131. Bruker Description and Major Businesses
    Table 132. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Bruker Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Bruker Recent Developments
    Table 135. SurgicEye Corporation Information
    Table 136. SurgicEye Description and Major Businesses
    Table 137. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. SurgicEye Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. SurgicEye Recent Developments
    Table 140. MIE Corporation Information
    Table 141. MIE Description and Major Businesses
    Table 142. MIE Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. MIE Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. MIE Recent Developments
    Table 145. MILabs Corporation Information
    Table 146. MILabs Description and Major Businesses
    Table 147. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. MILabs Nuclear Medicine Diagnostic (SPECT and PET) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. MILabs Recent Developments
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Nuclear Medicine Diagnostic (SPECT and PET) Distributors List
    Table 153. Nuclear Medicine Diagnostic (SPECT and PET) Customers List
    Table 154. Nuclear Medicine Diagnostic (SPECT and PET) Market Trends
    Table 155. Nuclear Medicine Diagnostic (SPECT and PET) Market Drivers
    Table 156. Nuclear Medicine Diagnostic (SPECT and PET) Market Challenges
    Table 157. Nuclear Medicine Diagnostic (SPECT and PET) Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nuclear Medicine Diagnostic (SPECT and PET) Product Picture
    Figure 3. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share by Type in 2021 & 2028
    Figure 3. SPECT Product Picture
    Figure 4. PET Product Picture
    Figure 5. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share by Application in 2021 & 2028
    Figure 6. Oncology
    Figure 7. Cardiology
    Figure 8. Neurology
    Figure 9. Others
    Figure 10. Nuclear Medicine Diagnostic (SPECT and PET) Report Years Considered
    Figure 11. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales 2017-2028 (K Units)
    Figure 12. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue 2017-2028 (US$ Million)
    Figure 14. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Region (2017-2022)
    Figure 16. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Region (2023-2028)
    Figure 17. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Nuclear Medicine Diagnostic (SPECT and PET) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Nuclear Medicine Diagnostic (SPECT and PET) in the World: Market Share by Nuclear Medicine Diagnostic (SPECT and PET) Revenue in 2021
    Figure 29. Global Nuclear Medicine Diagnostic (SPECT and PET) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Type (2017-2028)
    Figure 31. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Type (2017-2028)
    Figure 32. Global Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2017-2028)
    Figure 33. Global Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2017-2028)
    Figure 34. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Type (2017-2028)
    Figure 35. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Type (2017-2028)
    Figure 36. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2017-2028)
    Figure 37. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2017-2028)
    Figure 38. North America Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Country (2017-2028)
    Figure 39. North America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Country (2017-2028)
    Figure 40. U.S. Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Type (2017-2028)
    Figure 43. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2017-2028)
    Figure 45. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Country (2017-2028)
    Figure 47. Europe Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Country (2017-2028)
    Figure 48. Germany Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 49. France Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Region (2017-2028)
    Figure 59. China Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 62. India Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Country (2017-2028)
    Figure 74. Latin America Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Country (2017-2028)
    Figure 75. Mexico Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Nuclear Medicine Diagnostic (SPECT and PET) Revenue Share by Country (2017-2028)
    Figure 84. Turkey Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Nuclear Medicine Diagnostic (SPECT and PET) Revenue (2017-2028) & (US$ Million)
    Figure 87. Nuclear Medicine Diagnostic (SPECT and PET) Value Chain
    Figure 88. Nuclear Medicine Diagnostic (SPECT and PET) Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed